ARCHIVES

At Its Launch, STAR Trial Inherits Baggage Of Its Predecessor, P-1 Tamoxifin Study

This article is from The Cancer Letter archive.

Vol. 25 No. 22 | June 4, 1999

Download PDF Visit The Full Archive

Related Articles

‘Major Discover’ At FCRDC Is NF1 Gene, Report Says

November 30, 1990

With a “B” from USPSTF, Low-Dose CT Screening For Lung Cancer Earns Coverage Under ACA

August 2, 2013

Children With Recurrent Hodgkin’s Respond To Gemcitabine, Vinorelbine

March 27, 2009

Cooperative Groups: Insurer To Cover Patient Care Costs In Clinical Trials

December 4, 1998

Rauscher Disappointed In CREG Progress

October 1, 1976

Pfizer Begins Phase III Trial Of Sunitinib In NSCLC

September 28, 2007